Abacavir, dolutegravir, and lamivudine and Prezista (Darunavir Tablets)
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Prezista (Darunavir Tablets) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Coadministration with darunavir/ritonavir may modestly decrease the plasma concentrations of dolutegravir. The exact mechanism of interaction has not been established, but may partially involve ritonavir induction of dolutegravir metabolism via UGT1A1. In 15 study subjects, administration of dolutegravir 30 mg once daily with darunavir/ritonavir 600 mg/100 mg twice daily decreased dolutegravir peak plasma concentration (Cmax), systemic exposure (AUC) and trough plasma concentration (Cmin; 24 hours postdose) by 11%, 22% and 38%, respectively, compared to administration without darunavir/ritonavir. These changes are not considered clinically significant. Using cross-study comparisons to historical pharmacokinetic data, dolutegravir did not appear to affect the pharmacokinetics of darunavir or ritonavir.
- "Product Information. Tivicay (dolutegravir)." ViiV Healthcare, Research Triangle Park, NC.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: darunavir
Brand name: Prezista
Synonyms: Prezista
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Prialt
- Abacavir, dolutegravir, and lamivudine-Priftin
- Abacavir, dolutegravir, and lamivudine-Prikaan
- Abacavir, dolutegravir, and lamivudine-Prilo Patch
- Abacavir, dolutegravir, and lamivudine-Prilocaine
- Abacavir, dolutegravir, and lamivudine-Prilocaine and Epinephrine
- Prezista (Darunavir Tablets)-Abacavir, Lamivudine and Zidovudine Tablets
- Prezista (Darunavir Tablets)-Abacavir, lamivudine, and zidovudine
- Prezista (Darunavir Tablets)-Abaloparatide
- Prezista (Darunavir Tablets)-Abaloparatide Subcutaneous
- Prezista (Darunavir Tablets)-Abatacept
- Prezista (Darunavir Tablets)-Abatacept Auto-Injectors